Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 3/20 | 0.32 |
| ▸ | PYGL | P06737 | 2/20 | 0.32 |
| ▸ | PYGM | P11217 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28326624 | 0.89 | PYGM (0.34) | PYGM | |
| SCHEMBL27900812 | 0.88 | PYGM (0.33) | PYGBPYGLPYGM | |
| SCHEMBL513129 | 0.83 | PYGL (0.31) | PYGBPYGLPYGM | |
| SCHEMBL4849542 | 0.83 | KDM4E (0.33) | PYGBPYGLPYGM | |
| SCHEMBL5954319 | 0.82 | TK1 (0.37) | PYGBPYGLPYGM | |
| SCHEMBL27900813 | 0.81 | PYGB (0.34) | PYGBPYGLPYGM | |
| SCHEMBL28973925 | 0.78 | PYGB (0.33) | PYGBPYGLPYGM | |
| SCHEMBL7262195 | 0.77 | PYGM (0.36) | PYGM | |
| SCHEMBL7872134 | 0.75 | PYGB (0.31) | PYGBPYGM | |
| SCHEMBL6028061 | 0.75 | SLC28A1 (0.42) | PYGBPYGLPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102203253-B | Multi-exon skipping compositions for DMD | SAREPTA THERAPEUTICS, INC. (US) | 2016-04-06 | — | — | CN | disclosed |
| CN-104661664-A | Chiral control | WAVE LIFE SCIENCES PTY LTD | 2015-05-27 | — | — | CN | disclosed |
| CN-104245958-A | Detection of nucleic acids | SPEEDX PTY LTD | 2014-12-24 | — | — | CN | disclosed |
| EP-0506892-B1 | BORONATED NUCLEOSIDES | BORON BIOLOG INC (US) | 1997-10-08 | — | — | EP | disclosed |
| US-5659027-A | BORONATED AT RING NITROGEN OF PURINE OR PYRIMIDINE BASE OR AT AN AMINO SUBSTITUENT OF THE NUCLEOSIDE SUGAR | UNIVERSITY OF NORTH CAROLINA (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0649411-A4 | BORONATED COMPOUNDS. | BORON BIOLOG INC (US) | 1995-07-12 | — | — | EP | disclosed |
| EP-0649411-A1 | BORONATED COMPOUNDS | BORON BIOLOGICALS, INC. (US) | 1995-04-26 | — | — | EP | disclosed |
| US-5362732-A | Purine and pyrimidine bases N-boronated with-BH2CN,-BH3, -BF3,-BH2COOR or -BH2C/O/NHR, where R is H or alkyl; pharmaceutical comprising antihyperlipidemic, antiinflammatory or analgesic boronated compound and carrier | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1994-11-08 | — | — | US | disclosed |
| WO-1994001413-A1 | BORONATED COMPOUNDS | BORON BIOLOGICALS, INC. (US) | 1994-01-20 | — | — | WO | disclosed |
| EP-0506892-A4 | BORONATED NUCLEOSIDES | — | 1993-03-31 | — | — | EP | disclosed |
| US-5177198-A | PROCESS FOR PREPARING OLIGORIBONUCLEOSIDE AND OLIGODEOXYRIBONUCLEOSIDE BORANOPHOSPHATES | UNIVERSITY OF N.C. AT CHAPEL HILL (US) | 1993-01-05 | — | — | US | disclosed |
| EP-0506892-A1 | BORONATED NUCLEOSIDES. | BORON BIOLOG INC (US) | 1992-10-07 | — | — | EP | disclosed |
| US-5130302-A | Antiinflammatory agents or antitumor agents | BORON BILOGICALS, INC. (US) | 1992-07-14 | — | — | US | disclosed |
| WO-1991009048-A1 | BORONATED NUCLEOSIDES | BARON BIOLOGICALS, INC. (US) | 1991-06-27 | — | — | WO | disclosed |
| WO-1991008213-A1 | OLIGORIBONUCLOSIDE AND OLIGODEOXYRIBONUCLEOSIDE BORANOPHOSPHATES | BORON BIOLOGICALS, INC. (US) | 1991-06-13 | — | — | WO | disclosed |